Cite
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
MLA
Ma, Yihui, et al. “PDIA6 Promotes Pancreatic Cancer Progression and Immune Escape through CSN5-Mediated Deubiquitination of β-Catenin and PD-L1.” Neoplasia (New York, N.Y.), vol. 23, no. 9, Sept. 2021, pp. 912–28. EBSCOhost, https://doi.org/10.1016/j.neo.2021.07.004.
APA
Ma, Y., Xia, P., Wang, Z., Xu, J., Zhang, L., & Jiang, Y. (2021). PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1. Neoplasia (New York, N.Y.), 23(9), 912–928. https://doi.org/10.1016/j.neo.2021.07.004
Chicago
Ma, Yihui, Peiyi Xia, Zhengyang Wang, Jingjing Xu, Lan Zhang, and Yanan Jiang. 2021. “PDIA6 Promotes Pancreatic Cancer Progression and Immune Escape through CSN5-Mediated Deubiquitination of β-Catenin and PD-L1.” Neoplasia (New York, N.Y.) 23 (9): 912–28. doi:10.1016/j.neo.2021.07.004.